The ability to identify causal mutations and deliver a genetic diagnosis is the primary goal of personalized diagnostics. Identifying undiagnosed diseases with genomic tools will improve outcomes for patients and change the workflow in clinical centers. Furthermore, next gen sequencing (NGS) is being used with other techniques to offer a comprehensive diagnosis.
This conference will explore the best strategies for overcoming technical bottlenecks, gaining clinical adoption and commercializing tests for the personalized treatment of cancer, CV, and inherited diseases. Experts will be asked to share their experience on gaining regulatory approval.
At the CARS Congress you will have the opportunity to meet scholars and practising experts in the fields of radiology, surgery, engineering, informatics and healthcare management who have an interest in topics, such as